Sreenivasa Oruganti

Scientist I at GeoVax - Smyrna, GA, US

Sreenivasa Oruganti's Contact Details
HQ
678-384-7220
Location
Company
GeoVax
Sreenivasa Oruganti's Company Details
GeoVax logo, GeoVax contact details

GeoVax

Smyrna, GA, US • 20 - 49 Employees
BioTech/Drugs

GeoVax Labs, Inc., (NASDAQ: GOVX) is a clinical-stage biotechnology company developing human vaccines against infectious diseases using our Modified Vaccinia Ankara - Virus-Like Particle (MVA-VLP) vaccine platform. Our current development programs are focused on vaccines against COVID-19; Hemorrhagic Fever viruses such as Ebola (Zaire, Sudan), Lassa and Marburg; Malaria and Zika virus; and, Human Immunodeficiency Virus (HIV). We have also initiated programs to develop a broadly applicable immunotherapy against tumor associated antigen MUC1 that is expressed of many solid tumor types including breast, ovarian, gastric, liver, pancreas, renal and lymph nodes and immunotherapy to treat human papilloma virus (HPV)-induced cancers. For more information, visit www.geovax.com.

HIV/AIDS vaccine development Zika virus vaccine Malaria vaccine Hemorrhagic fever virus vaccine Hepatitis B vaccine Ebola vaccine Cancer vaccine development Lassa Fever vaccine Immuno-oncology biotechnology B2B Market Research Commercial Physical Research Biotechnology Biotech Pharmaceuticals
Details about GeoVax
Frequently Asked Questions about Sreenivasa Oruganti
Sreenivasa Oruganti currently works for GeoVax Labs, Inc..
Sreenivasa Oruganti's role at GeoVax Labs, Inc. is Scientist I.
Sreenivasa Oruganti's email address is ***@geovax.com. To view Sreenivasa Oruganti's full email address, please signup to ConnectPlex.
Sreenivasa Oruganti works in the Biotechnology industry.
Sreenivasa Oruganti's colleagues at GeoVax are Robert McNally, Todd Albrecht, Mary Hauser, Robert McNally, Dean Kollintzas, Rahul Basu, Mark Newman and others.
Sreenivasa Oruganti's phone number is 678-384-7220
See more information about Sreenivasa Oruganti